Diagnostically, it has been shown that exosomes contain specific molecules, such as Glypican-1 and CA19-9, from circulating tumour cells that can be used for diagnostic and prognostic purposes for patients with resectable tumours (Buscail et al. 2019a, b). Here, GPC1 is linked to neoplasm.